BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 16372885)

  • 1. Evolving perception on the benefits of vaccination as a foot and mouth disease control policy: contributions of South America.
    Bergmann IE; Malirat V; Falczuk AJ
    Expert Rev Vaccines; 2005 Dec; 4(6):903-13. PubMed ID: 16372885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-capsid proteins to identify foot-and-mouth disease viral circulation in cattle irrespective of vaccination.
    Bergmann IE; Malirat V; Neitzert E
    Biologicals; 2005 Dec; 33(4):235-9. PubMed ID: 16257539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination: foot-and-mouth disease experience in South America.
    Bergmann IE; Malirat V; Neitzert E; Correa Melo E
    Dev Biol (Basel); 2004; 119():273-82. PubMed ID: 15742639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of vaccines in South American foot-and-mouth disease eradication programmes.
    Saraiva V; Darsie G
    Dev Biol (Basel); 2004; 119():33-40. PubMed ID: 15742616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines and foot-and-mouth disease eradication in South America.
    Saraiva V
    Dev Biol (Basel); 2003; 114():67-77. PubMed ID: 14677678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foot-and-Mouth disease 'vaccination-to-live': possibilities and constraints.
    Roth JA
    Dev Biol (Basel); 2004; 119():267-72. PubMed ID: 15742638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an inhibition ELISA test for the detection of non-capsid polyprotein 3ABC in viral suspensions destined for inactivated foot-and-mouth disease vaccines.
    Bergmann IE; Neitzert E; Malirat V; de Mendonça Campos R; Pulga M; Muratovik R; Quintino D; Morgados JC; Oliveira M; de Lucca Neto D
    Dev Biol (Basel); 2006; 126():241-50; discussion 327. PubMed ID: 17058500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
    Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
    Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradication of foot-and-mouth disease in South America.
    Epidemiol Bull; 1998 Jun; 19(2):14-5. PubMed ID: 9734180
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccines and companion diagnostic tests for foot-and-mouth disease virus. An overview of the experience in South America.
    Bergmann IE; Malirat V; Neitzert E; Correa Melo E
    Dev Biol (Basel); 2003; 114():59-65. PubMed ID: 14677677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Making a vaccinate-to-live policy a reality in foot-and-mouth disease.
    Mackay D; Parida S; Paton D; Anderson J
    Dev Biol (Basel); 2004; 119():261-6. PubMed ID: 15742637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foot-and-mouth disease control using vaccination: South African experience.
    Brückner GK; Vosloo W; Cloete M; Dungu B; Du Plessis BJ
    Dev Biol (Basel); 2004; 119():51-62. PubMed ID: 15742618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis of foot and mouth disease].
    Haas B
    Dtsch Tierarztl Wochenschr; 2001 Dec; 108(12):508-13. PubMed ID: 11822165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Point of view of KNMvD concerning foot and mouth disease marker vaccine].
    van Leeuwen JM
    Tijdschr Diergeneeskd; 2001 Sep; 126(17):585. PubMed ID: 11596520
    [No Abstract]   [Full Text] [Related]  

  • 15. Control of foot and mouth disease: the experience of the Americas.
    Correa Melo E; López A
    Rev Sci Tech; 2002 Dec; 21(3):695-8, 689-94. PubMed ID: 12523707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vaccination against foot and mouth disease: current state and perspectives].
    Visser N; Thiel HJ
    Dtsch Tierarztl Wochenschr; 2001 Dec; 108(12):522-5. PubMed ID: 11822168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle.
    Paton DJ; de Clercq K; Greiner M; Dekker A; Brocchi E; Bergmann I; Sammin DJ; Gubbins S; Parida S
    Vaccine; 2006 Oct; 24(42-43):6503-12. PubMed ID: 16872727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid serological profiling by enzyme-linked immunosorbent assay and its use as an epidemiological indicator of foot-and-mouth disease viral activity.
    Bergmann IE; Neitzert E; Malirat V; Ortiz S; Colling A; Sánchez C; Correa Melo E
    Arch Virol; 2003 May; 148(5):891-901. PubMed ID: 12721797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foot and Mouth's Achilles' heel?
    Atkins JF; Ryan MD
    Nat Biotechnol; 2008 Dec; 26(12):1335-6. PubMed ID: 19060865
    [No Abstract]   [Full Text] [Related]  

  • 20. Eradication versus vaccination strategies to control infectious diseases--some lessons to be learned from terrestrial animals.
    Moennig V
    Dev Biol (Basel); 2005; 121():13-9. PubMed ID: 15962466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.